AcouSort AB (publ) (STO:ACOU)

Market Cap	67.72M +0.3%
Revenue (ttm)	9.31M -11.9%
Net Income	-11.22M
EPS	-0.53
Shares Out	21.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,893
Open	3.380
Previous Close	3.200
Day's Range	2.950 - 3.380
52-Week Range	2.030 - 5.160
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 23, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 11
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACOU

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error